Aleth

Open access research

Aleth (from the Greek for pure truth) is an open-access research platform focused on scientific innovation across life sciences, AI, and deep tech. Built AI-native with rigorous human oversight of the research process.

This site hosts our permanent research archive, while the live insights drop directly into your inbox. Subscribe for free via Substack to get our latest life sciences, AI and deep tech analysis the moment it’s published. Subscribe free at sub.aleth.co (opens in new tab)

ALETH / NOTES

• ALETH / LIFESCI-BRIEF / 2026-08-01 / RECORD HALF FOR BIOPHARMA M&A

  Record half for Biopharma M&A

  Aleth LifeSci Brief: 1 Aug 2026

• ALETH / LIFESCI-BRIEF / 2026-07-24 / BURNHAM ABOLISHES THE SCIENCE DEPARTMENT

  Burnham abolishes the science department

  Aleth LifeSci Brief: 24 Jul 2026

• ALETH / LIFESCI-BRIEF / 2026-01-30 / GRAIL FILES GALLERI FOR FDA APPROVAL

  Grail files Galleri for FDA approval

  Also this week: AZ commits $15bn to China, Roche’s obesity shot hits 22.5% weight loss & Medicare picks 15 more drugs for price talks.

• ALETH / LIFESCI-BRIEF / 2026-01-23 / SCOTUS TAKES UP HIGH-STAKES GENERICS BATTLE

  SCOTUS takes up high-stakes generics battle

  Also this week: GSK buys RAPT for $2.2bn, AZ leaves Nasdaq for the NYSE and Moderna pulls back from vaccine trials.

• ALETH / LIFESCI-BRIEF / 2026-01-16 / NEW WAVE OF MEGA-MERGERS IN 2026

  "New wave of mega-mergers in 2026"

  Aleth LifeSci Brief: 16 Jan 2026

• ALETH / LIFESCI-BRIEF / 2026-01-09 / MERCK IN $32BN REVOLUTION TALKS

  Merck in $32bn Revolution talks

  Aleth LifeSci Brief: 9 Jan 2026

• ALETH / LIFESCI-BRIEF / 2026-01-02 / INSILICO'S RECORD HONG KONG BIOTECH IPO

  Insilico's record Hong Kong biotech IPO

  Aleth LifeSci Brief: 2 Jan 2026

• ALETH / LIFESCI-BRIEF / 2025-12-29 / WEGOVY THE FIRST GLP-1 PILL FOR OBESITY

  Wegovy: the first GLP-1 pill for obesity

  Aleth LifeSci Brief: 29 Dec 2025

• ALETH / LIFESCI-BRIEF / 2025-12-19 / BRUSSELS UNVEILS ITS BIOTECH ACT

  Brussels unveils its Biotech Act

  Aleth LifeSci Brief: 19 Dec 2025

• ALETH / LIFESCI-BRIEF / 2025-12-12 / UK CUTS DRUG REBATE IN PHARMA RESET

  UK cuts drug rebate in pharma reset

  Aleth LifeSci Brief: 12 Dec 2025

• ALETH / LIFESCI-BRIEF / 2025-12-05 / US AND UK STRIKE A ZERO-TARIFF DRUG DEAL

  US and UK strike a zero-tariff drug deal

  Aleth LifeSci Brief: 5 Dec 2025

• ALETH / LIFESCI-BRIEF / 2025-11-28 / LILLY BECOMES THE FIRST $1TN DRUGMAKER

  Lilly becomes the first $1tn drugmaker

  Aleth LifeSci Brief: 28 Nov 2025

• ALETH / LIFESCI-BRIEF / 2025-11-21 / ABBOTT BUYS EXACT SCIENCES FOR $23BN

  Abbott buys Exact Sciences for $23bn

  Aleth LifeSci Brief: 21 Nov 2025

• ALETH / LIFESCI-BRIEF / 2025-11-14 / BIG CARDIO PROGRESS AT AHA

  Big cardio progress at AHA

  Aleth LifeSci Brief: 14 Nov 2025

• ALETH / LIFESCI-BRIEF / 2025-11-07 / PFIZER AND NOVO GO TO WAR OVER METSERA

  Pfizer and Novo go to war over Metsera

  Aleth LifeSci Brief: 7 Nov 2025

• ALETH / LIFESCI-BRIEF / 2025-10-31 / NOVO GOES HOSTILE ON METSERA TO OUTBID PFIZER

  Novo goes hostile on Metsera to outbid Pfizer

  Aleth LifeSci Brief: 31 Oct 2025

• ALETH / LIFESCI-BRIEF / 2025-10-24 / HOLOGIC THE BIGGEST DEVICE BUYOUT IN 20 YEARS

  Hologic the biggest device buyout in 20 years

  Aleth LifeSci Brief: 24 Oct 2025

• ALETH / LIFESCI-BRIEF / 2025-10-17 / ELLISON’S EIT TO INVEST AN EXTRA $1.2BN IN OXFORD

  Ellison's EIT to invest an extra $1.2bn in Oxford

  Aleth LifeSci Brief: 17 Oct 2025

• ALETH / LIFESCI-BRIEF / 2025-10-10 / PHARMA STOCKS ADD $440BN AFTER PRICING DEAL

  Pharma stocks add $440bn after pricing deal

  Aleth LifeSci Brief: 10 Oct 2025

• ALETH / LIFESCI-BRIEF / 2025-10-03 / GENMAB TO BUY DUTCH BIOTECH MERUS FOR $8BN

  Genmab to buy Dutch biotech Merus for $8bn

  Aleth LifeSci Brief: 3 Oct 2025

* * *

Subscribe for free to receive in your inbox at: sub.aleth.co (opens in new tab).